Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P970004/S457

InterStim Therapy System, Verify Evaluation System

Medtronic Neuromodulation · Decision date Oct 6, 2026

MEDTECHLEDGER EXPLANATIONP970004/S457

What did the FDA approve?

FDA recorded an approval decision dated 2026-10-06 for PMA supplement P970004/S457, submitted by Medtronic Neuromodulation under the InterStim™ Therapy System, Verify™ Evaluation System title. The supplement is classified as a Real-Time Process submission with the stated reason Change Design/Components/Specifications/Material, and the recorded statement describes a new stand-alone torque wrench kit configuration (Model B31020-T).

The decision applies to that supplement within the existing P970004 approval rather than constituting a new approval of the whole system. The device category is listed as Stimulator, electrical, implantable, for incontinence, with Gastroenterology and Urology specialties and product code EZW. The source record does not include the supplement documents, so the technical basis for the change and any conditions of approval remain unknown from this data alone.

FDA approval order statement

a new stand-alone torque wrench kit configuration (Model B31020-T)
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 6, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P970004/S457
Regulatory pathway
PMA supplement
Product code
EZW
Decision code
APPR
Decision date
Oct 6, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implantable, for incontinence.

Product code
EZW
FDA device class
3

For the original device and its historical approval scope, see PMA P970004. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P970004 · Original PMA

    MEDTRONIC INTERSTIM THERAPY SYSTEM FOR URINARY CONTROL

  2. P970004/S457 received

    Application receipt date recorded by FDA.

  3. P970004/S458 · Related supplement

    InterStim Therapy System Verify Evaluation System

  4. P970004/S457 · FDA decision

    Real-Time Process

  5. P970004/S459 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  6. P970004/S460 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Urinary Neurostimulator 97800), (SNS Urinary Neurostimulator I

Timeline entries are records held by MedtechLedger for P970004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P970004

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records